Latest news with #drugdelivery
Yahoo
3 days ago
- Business
- Yahoo
CraniUS Therapeutics Awarded Maryland Tech Council's "2025 Emerging Life Sciences Company of the Year"
BALTIMORE, May 29, 2025 /PRNewswire/ -- CraniUS Therapeutics, a cutting-edge medical device company advancing intracranial drug delivery, is proud to announce it has been voted the "2025 Emerging Life Sciences Company of the Year" by the Maryland Tech Council (MTC). The honor was presented during the Council's prestigious Industry Awards Celebration, which drew over 600 attendees, and recognizes the state's most innovative and impactful companies in technology and life sciences. The company's Founder and Executive Chairman, Dr. Chad Gordon, is a leader in Neuroplastic and Reconstructive Surgery. He serves as Section Chief and Fellowship Program Director at Johns Hopkins School of Medicine. Over his career, Dr. Gordon has secured 21 patents, led three successful venture exits, and conducted three first-in-human studies evaluating advanced cranial implants. His invention of the NeuroPASS™ device—CraniUS's core innovation—sparked the company's formation. This award acknowledges CraniUS's leadership and its groundbreaking development of the NeuroPASS™ platform, which enables direct, reliable delivery of therapeutics to the brain—addressing one of the most persistent challenges in treating brain tumors and other neurological conditions. "We are honored to be recognized by the Maryland Tech Council with this year's Emerging Company Award," said Dr. Gordon. "This milestone reflects not only the dedication of our entire team but also the urgent need for transformative solutions in neurotherapeutics. We are extremely proud to be pioneering the new field of functional neurocranial implants inspired by Neuroplastic Surgery and driving this critical work forward—from right here in Maryland." Mike Maglin, CEO of CraniUS Therapeutics, added, "This award is a testament to the meaningful progress we've made and the momentum we've built—spanning scientific innovation, strategic alliances, and investor engagement. We remain committed to redefining how patients with neurological diseases receive life-changing medicines." The Industry Awards Celebration is Maryland's premier event honoring excellence in technology, life sciences, and innovation. CraniUS was selected from a competitive field of nominees for its rapid growth, strong leadership, and the promise of its revolutionary device platform—employing patented neurotechnology—designed to reshape treatment approaches for conditions such as neurodegenerative diseases, movement disorders, and aggressive brain cancers. About CraniUS TherapeuticsCraniUS Therapeutics is a neurotechnology company developing the first fully implantable platform to bypass the blood-brain barrier for long-term, programmable drug delivery. Its flagship device, NeuroPASS™, is designed to transform the treatment landscape for debilitating neurological conditions across multiple disease types. CraniUS Therapeutics is headquartered in Baltimore, Maryland, and collaborates globally with industry leading experts in neurosurgery, drug delivery, implant design, device engineering, and manufacturing. Media Contact:Elizabeth A. Dale, EdDExecutive Advisor, CraniUS Therapeuticsedale@ View original content to download multimedia: SOURCE CraniUS Therapeutics Melden Sie sich an, um Ihr Portfolio aufzurufen.
Bloomberg
5 days ago
- Business
- Bloomberg
From Your Fridge to the Pharmacy, how Tariffs Could Disrupt It All
Aptar is a US-based global manufacturer of consumer dispensing packaging and drug delivery devices with manufacturing operations in 18 countries. The company makes packaging for everyday products like Kraft-Heinz Ketchup and Lysol air fresheners. Stephan Tanda, Aptar Group President & CEO joined the C-Suite on Bloomberg Open Interest to talk about how he's positioning his company as tariff tensions ebb and flow. (Source: Bloomberg)
BBC News
5 days ago
- Business
- BBC News
'Trusted courier' jailed over Londonderry cannabis haul
A man described in court as a "trusted courier" has been jailed for two years after being found with more than four kilos of cannabis in his Chan, 38, from Creswick Avenue, Essex, pleaded guilty at Londonderry Crown Court on discovered eight vacuum bags of cannabis in his car when it was stopped on the Culmore Road in Derry on 4 August Judge Neil Rafferty said: "It is quite clear he was acting in the role of a trusted courier making deliveries to known people throughout the island of Ireland." The court was told police also found four handwritten lists of addresses in Northern Ireland and in Galway and Dublin, in the Republic of judge also ordered that £300 found inside the car should be donated to the local branch of Marie Curie. 'No previous convictions' Judge Rafferty said Chan, who has been in custody since his arrest, had previously lived in Ballymena, County Antrim, and Holywood in County court was told Chan had previously worked on oil rigs and who opened a shop when he moved to became involved in supplying drugs after he was forced to close his shop due to the economic Rafferty said the defendant had become a delivery driver for drugs gangs."He had no drugs issues himself and never used drugs and had no previous convictions until he pleaded guilty to this criminality," the judge added.
Yahoo
6 days ago
- Business
- Yahoo
Rapid Dose Therapeutics and Aavishkar Oral Strips File Two Key Patents for Innovative Nicotine Delivery Technology
Burlington, Ontario--(Newsfile Corp. - May 26, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company"), a Canadian life sciences company specializing in innovative drug delivery solutions through its QuickStrip™ platform, today announced the filing of two critical patent applications in partnership with Aavishkar Oral Strips Pvt. Ltd. These patents cover both dissolvable and non-dissolvable oral nicotine strips-representing a breakthrough in nicotine delivery. These next-generation strips are designed for administration, similar to existing oral pouches, but with significantly faster absorption, improved bioavailability, and no need for removal after use. While provisional patents were submitted in July 2024, the new international PCT applications filed with the World Intellectual Property Organization (WIPO) mark a major advancement. The filings extended potential protection to up to 158 jurisdictions worldwide, reinforcing the strategic global positioning of this novel nicotine replacement therapy. "These patent filings reflect a pivotal milestone in our commitment to reimagining nicotine consumption," said Mark Upsdell, CEO of Rapid Dose Therapeutics. "By combining the convenience and familiarity of pouch formats with rapid action of our QuickStrip™ technology, we are delivering a discreet, fast-acting alternative for adult nicotine users looking to transition away from combustible tobacco and vaping." Unlike traditional pouches that rely on slower buccal absorption, RDT's dissolvable QuickStrip™ nicotine strip enables nicotine delivery in under 2 minutes-offering rapid onset of effect. In parallel, the non-dissolvable variant provides extended release in a slim, discreet, and user-friendly format, appealing to a broad spectrum of adult users and aligning with evolving regulatory preferences. A Global Opportunity to Support Smoking and Vaping Cessation According to the World Health Organization, more than 1.3 billion people worldwide use tobacco products or vape nicotine, contributing to over 7 million deaths annually directly attributable to tobacco use. Independent research indicates that up to 60% of smokers want to quit, yet the lack of effective, convenient and discreet alternatives remain a critical barrier to success. QuickStrip aims to change that. "Even a modest shift-just a small percentage of smokers transitioning to our QuickStrip nicotine products-could deliver a profound public health benefit," said Jason Lewis, Co-Developer and Senior Vice President of RDT. "We believe this innovative format will resonate with a growing global population of adult users seeking modern, smoke-free solutions that are fast-acting, easy to use and unobtrusive." Building on Momentum: Partnership with Global Tobacco Leader These patent filings follow the previously announced pre-commercialization development agreements with a leading global tobacco company, as previously disclosed by RDT on January 28, 2025. The collaboration encompasses early-stage development and validation of QuickStrip nicotine technologies - underscoring industry recognition and growing confidence in RDT's ability to deliver innovative, consumer-centric nicotine alternatives. "With the support of a global industry leader and the successful filing of these two key patents, we are strongly positioned to introduce our novel nicotine delivery solutions to regulated markets worldwide," added Mark Upsdell, CEO of Rapid Dose Therapeutics. RDT and its partner Aavishkar remain committed to operating within stringent regulatory frameworks and, together with their partner(s), will pursue the necessary approvals to bring these products to market across multiple jurisdictions. Regulatory submissions and clinical validation activities are scheduled for the coming calendar quarters. For further information and future updates, visit About Rapid Dose Therapeutics Rapid Dose Therapeutics is a Canadian biotechnology company specializing in innovative, proprietary drug delivery technologies. Its flagship product, QuickStrip™, is a fast-dissolving oral thin film designed to deliver active ingredients rapidly, efficiently, and with high bioavailability. About Aavishkar Oral Strips Pvt. Ltd. Based in India, Aavishkar Oral Strips is a research-driven pharmaceutical and wellness company specializing in oral thin film technologies. The company partners globally to bring advanced delivery systems to the nutraceutical, pharmaceutical, and tobacco-free nicotine sectors. Media Contact:Investor Relations Mark UpsdellRapid Dose Therapeutics (416) 477-1052 CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "intend", "may", "should", "anticipate", "expect", "potential", "believe", "intend", "will", "could", "are planned to", "are expected to" or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of equipment and products using the QuickStrip™ product delivery method, the generation of recurring revenues, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, statements pertaining to the use of funds from the Financing and the anticipated closing of the Financing and Shares for Debt Transaction, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities described herein in the United States. The securities described in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. To view the source version of this press release, please visit Sign in to access your portfolio
Malay Mail
21-05-2025
- Malay Mail
Cat-ch me if you can: Prison guards nab drug mule kitty in Costa Rica
SAN JOSÉ (Costa Rica), May 21 — Guards in Costa Rica have intercepted an unusual prison drug delivery, catching a cat as it jumped over the periphery fence at night with marijuana and crack taped to its body. The black-and-white feline, carrying over 230 grams of marijuana and 67 grams of crack cocaine in two packages, was captured this month at a prison in the canton of Pococi, the justice ministry said in a statement yesterday. It shared a video of a guard climbing a perimeter fence to catch the cat burglar. Later, the feline is seen on a prison table while guards cut the packages from its tiny body. 'Thanks to the quick actions (of the guards) the feline was caught and the packages were removed, thus preventing them from reaching' the inmates, said the ministry. The cat was taken to an animal welfare society. — AFP
